Each one in plain English, with the numbers worked through for a shareholder.
22 Oct 2026agm notice● Neutral
Chair's address for the 22 October scheme meetings, run by an independent lawyer. It restates the 0.045 ratio and the 29 October record date. Results were not yet in this announcement; the schemes are inter-conditional and still need court approval.
The CRML average price over the 20-day period was at or below US$8, so the maximum ratio applies: 0.045 CRML shares per EUR share. Holders of about 777 or fewer shares get cash via the sale facility. Final option consideration is due 28 October.
Notice that the Court will hear the application to approve the CRML schemes at 10:00am on 26 October 2026, after meetings on 22 October. Cash is above the minimum required; the Millstone agreements were varied to satisfy that condition; the unlisted options cancellation-deed condition is waived.
Routine governance filing (Appendix 4G) confirming where the corporate governance statement can be found on the company website, current as at 30 September 2026. No new business information.
Annual report for year to 30 June 2026 shows a net profit of A$930.6M, driven by a A$1,275.5M gain on deconsolidating CRML, offset by a A$163.1M impairment and A$129.3M share of associate losses. The profit is an accounting gain, not cash; no dividend.
The scheme booklet and proxy forms were dispatched on 22 September. The independent board committee still recommends voting in favour. Optionholders may instead exercise options before 28 October; the opt-in deadline for cash sale is 27 October.
The court ordered meetings of shareholders and optionholders on the CRML schemes. The independent expert (now Horizon Nexus) found the share scheme not fair but reasonable, so in shareholders' best interests, and the option scheme fair and reasonable. The independent board committee recommends voting for.
ASIC registered the scheme booklet. Horizon Nexus calls the share scheme not fair but reasonable, and the independent director recommends voting for it, absent a superior proposal. He would receive personal benefits if it completes. Small holders must opt in for cash sale by 27 October.
The draft scheme booklet was lodged with ASIC on 26 August and the first court hearing is set for 15 September. Scheme meetings are now expected in mid-October and implementation in early November 2026, later than the October previously guided.
The deal's fixed 0.035 ratio is replaced by a floating ratio from 0.025 to 0.045 CRML shares per EUR share, set by CRML's 20-day average price between US$16 and US$8. At the current sub-US$8 price, 0.045 applies, 28.6% more shares. EUR holders would own about 38%.
June quarter report: cash of A$296.3M at 30 June, down from about A$356M earlier in the year. The CRML scheme deed was signed. Leinster Northern Block sampling covers about 30% of the area; Southern Block assays are still awaited.
ASX granted EUR a waiver on 22 July so unlisted options and performance rights can be cancelled for CRML shares or warrants without a shareholder vote, conditional on the schemes taking effect. EUR has 1.726 billion shares and 242M listed options on issue.
EUR and CRML amended the scheme deed: holders of 50,000 or fewer shares or options can opt to have their CRML shares sold for cash, and shares are issued directly with no CDIs. Ratio is unchanged at 0.035; implementation slips to October 2026, with about 41% ownership.
EUR says the CRML scheme is on track. Nexia Perth is the independent expert, with its report not yet final. Booklet expected late July, meetings late August and implementation early September 2026. No shareholder action needed.
Routine notice after 2,000,000 shares were issued on exercise of A$0.12 options. It repeats that EUR holders will receive CRML shares directly, with no CDIs, and that mechanics are still being finalised.
Routine notice after 6,669,761 shares were issued on option exercises. It also says no CDIs will be set up, so EUR holders will receive CRML shares directly rather than ASX-traded CDIs. This changes the earlier CDI possibility; mechanics are still to be finalised.
EUR signed a binding deal for CRML to acquire all of EUR by scheme at 0.035 CRML shares per EUR share (implied A$0.58, 137% premium). EUR holders would own about 41% of the combined group, down from the ~45% proposed. Listed options convert on a cashless basis.
EUR and CRML finished mutual due diligence and extended exclusivity to finalise a binding scheme implementation deed. Terms are unchanged at 0.035 CRML shares per EUR share, with listed options converted on a cashless basis.
EUR answered an ASX query on the CRML proposal, saying it first became aware of it on signing 25 April and that earlier talks were covered by disclosure exceptions. It had halted trading on 24 April after an AFR article on 23 April.
In a follow-up ASX reply, EUR said it first entered negotiations with CRML on 17 March 2026 and confirmed it complies with Listing Rule 3.1. The Board authorised the response.
March quarter report: 7.5M CRML shares sold for A$167.6M, 3,430m of Tanbreez drilling completed, Irish northern block sampling started. It also repeats the Tanbreez 92.5% approval and the CRML merger proposal; a new buy-back was announced 1 April.
EUR signed a non-binding proposal for CRML to acquire all EUR shares by scheme at 0.035 CRML shares each, valued at A$0.58 (137% premium to last close). EUR holders would own about 45% of the combined company; exclusivity runs to 7 May for binding documents.
Greenland's government approved transfer of the remaining 50.5% of Tanbreez to CRML, taking it to 92.5%; EUR keeps 7.5%. This resolves the pending approval step and the open thread on CRML's stake.
Half-year to 31 December 2025 shows net profit of A$1.146 billion, driven by a A$1.276 billion gain on deconsolidating CRML, offset by A$74M share of associate losses and A$47.7M tax. The gain is an accounting effect of the CRML stake.
S&P Dow Jones Indices announced EUR will be added to the All Ordinaries index from 23 March 2026. This is an index notice, not a company announcement, and carries no operational news.
EUR lodged a prospectus for 9,000,000 EUROC options offered to Evolution Capital (or nominees). The text shown is mostly legal boilerplate and does not state the exercise terms or the reason; Evolution Capital took shortfall shares in the earlier offer.
CRML reported resampling of 33 holes drilled in 2010 at Tanbreez's Hill deposit: weighted average 0.44% rare earths (range 0.31%-0.94%), about 24% heavy. It validates the historical data; no change to the resource, and infill drilling is planned for 2026.
CRML reported final 2025 Tanbreez assays from Area B and the Fjord deposit, with 0.40% to 0.47% rare earths. Area B shows broad mineralisation next to the Hill deposit; extension drilling is planned for 2026 and a resource update is expected.
5 Feb 2026asset acquisition disposition▲ GoodMajor
EUR sold another 2.5 million CRML shares for about A$45 million, lifting cash to about A$356 million. It holds 45,536,338 CRML shares and does not expect to sell more over the next four months.